Statement: PCAB Applauds Continued Access to Compounded Access to 17-hydroxyprogesterone
Washington, D.C. – The Pharmacy Compounding Accreditation Board (PCAB) applauds the FDA's recent statement regarding continued access to compounded versions of 17-hydroxyprogesterone, for which there is now an FDA approved drug product, Makena®. 17-hydroxyprogesterone is prescribed to reduce the risk of certain preterm births in women who have had at least one prior preterm birth.

Pharmacy compounding non-profit reaches major milestone
PCAB offers patients more than 100 accredited locations nationwide
WASHINGTON, DC - The Pharmacy Compounding Accreditation Board (PCAB) announced today that it had reached a major milestone by accrediting its 100th pharmacy. These 100 PCAB accredited pharmacies are located in 34 states and another 150 pharmacies have applied for accreditation.

Local Pharmacy is First in Region to Earn Top Quality & Safety Endorsement
Pharmacy Innovations earns new accreditation status, high marks on quality and safety
October 20, 2006

Local Pharmacy is Nation’s First to Earn Safety Accreditation
The Compounding Shoppe earns new accreditation status, high marks on quality and
safety
September 20, 2006

Local Pharmacy is First in Region to Earn Top Quality & Safety Endorsement
The Apothecary Shops earns new accreditation status, high marks on quality and safety
September 19, 2006

PHARMACY GROUPS CREATE COMPOUNDING ACCREDITATION BOARD
Leading Organizations Pioneer Effort to Improve Patient Care
April 15, 2004